These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6204904)

  • 1. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol.
    Liddle RA; Goldfine ID; Williams JA
    Gastroenterology; 1984 Sep; 87(3):542-9. PubMed ID: 6204904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.
    Liddle RA; Goldfine ID; Rosen MS; Taplitz RA; Williams JA
    J Clin Invest; 1985 Apr; 75(4):1144-52. PubMed ID: 2580857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioassay of plasma cholecystokinin in rat and human: inhibition of protein synthesis prevents the decrease in the sensitivity and responsiveness of isolated rat pancreatic acini to CCK-8.
    Otsuki M; Okabayashi Y; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Baba S
    Pancreas; 1989; 4(4):447-51. PubMed ID: 2474813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
    Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
    Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between the synthetic cholecystokinin analogues caerulein and Thr28NlE31CCK25-33(CCK9) with regards to plasma bioactivity, degradation rate and stimulation of pancreatic exocrine function.
    Mössner J; Sprenger C; Secknus R; Kestel W; Fischbach W
    Z Gastroenterol; 1991 Feb; 29(2):59-64. PubMed ID: 1714671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bioassay for plasma cholecystokinin bioactivity].
    Sun G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Dec; 13(6):417-21. PubMed ID: 1724414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats.
    Chowdhury P; Rayford PL
    Ann Clin Lab Sci; 2001 Oct; 31(4):376-82. PubMed ID: 11688849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic digestive enzyme gene expression: effects of CCK and soybean trypsin inhibitor.
    Rosewicz S; Lewis LD; Wang XY; Liddle RA; Logsdon CD
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G733-8. PubMed ID: 2468294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of alcohol administration on the trophic effect of soybean trypsin inhibitor and cholecystokinin octapeptide in rat.
    Pap A; Nagy I; Takács T; Hajnal F; Tóth G; Varró V
    Int J Pancreatol; 1989 Oct; 5(3):263-72. PubMed ID: 2476519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin-induced residual stimulation of enzyme secretion from mouse pancreatic acini.
    Younes M; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1987 Oct; 930(3):410-8. PubMed ID: 2443185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of cholecystokinin-induced persistent stimulation of pancreatic enzyme secretion by dibutyryl cyclic GMP.
    Collins SM; Abdelmoumene S; Jensen RT; Gardner JD
    Am J Physiol; 1981 Jun; 240(6):G466-71. PubMed ID: 6166201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretagogue-induced membrane alterations in dispersed acini from rat pancreas.
    Adler G; Kern HF; Pan GZ; Gardner JD
    Eur J Cell Biol; 1984 Mar; 33(2):234-41. PubMed ID: 6325191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of feeding soybean trypsin inhibitor and repeated injections of cholecystokinin on rat pancreas.
    Temler RS; Dormond CA; Simon E; Morel B
    J Nutr; 1984 Jun; 114(6):1083-91. PubMed ID: 6202862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A soluble interaction between dibutyryl cyclic guanosine 3':5'-monophosphate and cholecystokinin: a possible mechanism for the inhibition of cholecystokinin activity.
    Miller LJ; Reilly WM; Rosenzweig SA; Jamieson JD; Go VL
    Gastroenterology; 1983 Jun; 84(6):1505-11. PubMed ID: 6301926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643.
    Obourn JD; Frame SR; Bell RH; Longnecker DS; Elliott GS; Cook JC
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):425-36. PubMed ID: 9266817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats.
    Yamamoto M; Otani M; Jia DM; Fukumitsu K; Yoshikawa H; Akiyama T; Otsuki M
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beer but not wine, hard liquors, or pure ethanol stimulates amylase secretion of rat pancreatic acinar cells in vitro.
    Gerloff A; Singer MV; Feick P
    Alcohol Clin Exp Res; 2009 Sep; 33(9):1545-54. PubMed ID: 19485972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
    Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
    Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes in the rat is associated with a reversible postreceptor defect in cholecystokinin action.
    Otsuki M; Goldfine ID; Williams JA
    Gastroenterology; 1984 Oct; 87(4):882-7. PubMed ID: 6205933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of canine intestinal cholecystokinin-58.
    Eysselein VE; Deveney CW; Sankaran H; Reeve JR; Walsh JH
    Am J Physiol; 1983 Aug; 245(2):G313-20. PubMed ID: 6192728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.